Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LAURUS LABS Gains 5%; BSE HEALTHCARE Index Up 1.1%
Fri, 22 Nov 13:20

LAURUS LABS  Gains 5%; BSE HEALTHCARE Index Up 1.1%Image source: Eoneren/www.istockphoto.com

LAURUS LABS share price has zoomed 5% and is presently trading at Rs 513.7.

Meanwhile, the BSE HEALTHCARE index is at 42,916.4 (up 1.1%).

Among the top gainers in the BSE HEALTHCARE index today are SUN PHARMA ADV. RES. (up 8.0%) and KIMS (up 2.9%).

GLAND PHARMA (down 1.2%) and Natco Pharma (down 1.2%) are among the top losers today.

Over the last one year, LAURUS LABS has moved up from Rs 367.9 to Rs 513.7, registering a gain of Rs 145.9 (up 39.6%).

On the other hand, the BSE HEALTHCARE index has moved up from 29,583.1 to 42,916.4, registering a gain of 45.1% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 162.0%), SUVEN PHARMACEUTICALS (up 118.3%) and FORTIS HEALTHCARE (up 88.4%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 78,295.2 (up 1.5%).

The top gainers among the BSE Sensex today are SBI (up 3.8%) and MUNDRA PORT & SEZ (up 2.6%). The most traded stocks in the BSE Sensex are Power Grid Corp. and MUNDRA PORT & SEZ.

In the meantime, NSE Nifty is at 23,701.2 (up 1.5%). SBI and Trent are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,655.2 to 78,295.2, registering a gain of 12,640.1 points (up 19.3%).

LAURUS LABS Financial Update...

LAURUS LABS net profit fell 54.9% YoY to Rs 177 million for the quarter ended September 2024, compared to a profit of Rs 393 million a year ago. Net sales declined 0.1% to Rs 12,237 million during the period as against Rs 12,245 million in July-September 2023.

For the year ended March 2024, LAURUS LABS reported 78.9% decrease in net profit to Rs 1,682 million compared to net profit of Rs 7,966 million during FY23. Revenue of the company fell 16.6% to Rs 50,408 million during FY24.

The current Price to earnings ratio of LAURUS LABS , based on rolling 12 month earnings, stands at 212.4.


Equitymaster requests your view! Post a comment on "LAURUS LABS Gains 5%; BSE HEALTHCARE Index Up 1.1%". Click here!